Pharmafile Logo
Pharmafocus logo
Advanced Search
astrazeneca_sign_sky

AstraZeneca could abandon US regulatory efforts for COVID-19 vaccine

March 18, 2022
Medical Communications

The Oxford/AstraZeneca vaccine has not yet been approved in the US, and has not been submitted for Emergency Use Authorisation …

News

Global COVID-19 cases up for first time in weeks

March 17, 2022
Business Services

After more than a month of decline, global cases of COVID-19 have increased. WHO have stated that cases of the …

News

War in Ukraine could worsen COVID-19 pandemic, says WHO

March 17, 2022
Business Services

WHO has expressed concern that the war in Ukraine could worsen the COVID-19 pandemic, and it is aiming to do …

News

Ukraine: Health facilities a “target” of war

March 17, 2022
Business Services

Healthcare facilities have become a “target” of war, WHO has said, warning that the health system in Ukraine is “teetering …

News

Targeted drug Olaparib improves survival in early-stage breast cancer

March 17, 2022
Business Services

The Institute of Cancer Research (ICR), London, has reported new findings that the targeted drug olaparib improves survival in women …

News

Shaping the new frontiers of women’s health

March 16, 2022

 March 8 was International Women’s Day and provided a perfect opportunity for Pharmafocus to dive deep into women’s health. Lina …

Feature

Sanofi and Seagen collaborate to develop novel antibody-drug conjugates

March 16, 2022
Research and Development

Sanofi and Seagen announced an exclusive collaboration agreement to design, develop, and commercialise antibody-drug conjugates (ADCs) for up to three …

News
national-cancer-institute-uurfmwa25f0-unsplash

NICE guidance for treating relapsed and refractory multiple myeloma

March 16, 2022
Research and Development

NICE has published guidance from the new cancer drug, daratumumab, for the treatment of relapsed and refractory myeloma. Around 350 …

News

FDA approves Symbicort to treat asthma and COPD

March 16, 2022
Research and Development

The FDA has approved the first generic of Symbicort (budesonide and formoterol fumarate dihydrate) Inhalation Aerosol, for the treatment of …

News

FDA clearance for clinical surveillance solution

March 16, 2022
Research and Development

The latest Philips Capsule Surveillance solution has received market clearance from the FDA, paving the way for widespread deployment across …

News

Sanofi and Blackstone Life Science collaborate to advance multiple myeloma treatment

March 15, 2022
Manufacturing and Production

Sanofi and Blackstone announced a strategic, risk-sharing €300 million collaboration, to advance innovative treatment for multiple myeloma. This funding will …

News

Grifols XEMBIFY receives European approvals

March 15, 2022
Manufacturing and Production

Grifols has announced that XEMBIFY, its innovative 20% subcutaneous immunoglobulin (SCIG), has been approved by several European Union member state …

News

Groundbreaking comprehensive genomic profiling test for cancer

March 15, 2022
Manufacturing and Production

Illumia have announced the launch of TruSight™ Oncology (TSO) Comprehensive (EU), a single test that assesses multiple tumour genes and …

News

Almirall announces collaboration with University of Michigan

March 15, 2022
Manufacturing and Production

Almirall has announced a collaboration agreement with the University of Michigan to accelerate the understanding of the factors that trigger …

News

CanSinoBIO’s Convidecia effective as booster against Omicron

March 14, 2022
Sales and Marketing

According to an academic paper on the efficacy of CanSinoBIO’s recombinant COVID-19 vaccine, published on medRxiv, the vaccine is effective …

News
e-6olmfwuay74lr

UK Health Secretary: rise in COVID-19 cases ‘expected’

March 14, 2022
Sales and Marketing

A surge in COVID-19 cases was to be “expected”, following the ease of pandemic restrictions in England, insisted UK Health …

News

First and only approved medicine in US targeting BRCA mutations in early breast cancer

March 14, 2022
Sales and Marketing

LYNPARZA® (olaparib) has been approved in the US for the adjuvant treatment of patients with germline BRCA-mutated (gBRCAm) HER2-negative high-risk …

News

Faron identifies gene mutation to better outcomes for ARDS patients

March 14, 2022

Faron Pharmaceuticals has announced the publication of research identifying a novel disease association between a single nucleotide polymorphism (SNP) in …

News

Valneva provides regulatory update on COVID-19 vaccine candidate

March 11, 2022
Medical Communications

Valneva has announced an update on the regulatory review of its inactivated COVID-19 vaccine candidate VLA2001, by the CHMP.The company …

News
liam-burnett-blue-t7xx-ko7vso-unsplash

Asia’s COVID-19 deaths surpass one million

March 11, 2022
Medical Communications

A Reuters tally has revealed that Asia passed the milestone of one million coronavirus-linked deaths on Friday 11 March. A …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025